On March 10, 2023, Sensei Biotherapeutics, Inc. announced that it has confirmed that Apeiron Investment Group Ltd. has nominated 3 candidates to stand for election to the Company's Board of Directors at the Company's 2023 annual meeting of stockholders. The Company stated that the members of the Board and management team have engaged in discussions with representatives of Apeiron and during the course of these discussions and in public communications, Apeiron has suggested proposals for the Board's consideration, including that the Company conduct a tender offer as a means to return capital to stockholders. In addition, the Company stated that it will review the proposed nominees and will present its formal recommendation with respect to the election of directors and other matters to be considered at the annual meeting in the Company's definitive proxy statement.